Registration statement for securities issued by foreign private issuers in certain business combination transactions

Segment Information - Consolidated Statements of Profit and Loss (Details)

v3.22.1
Segment Information - Consolidated Statements of Profit and Loss (Details) - USD ($)
$ in Thousands
 3 Months Ended 12 Months Ended
Mar. 31, 2022
Mar. 31, 2021
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2019
Disclosure of operating segments [line items]          
Revenue $ 266,446 $ 71,293 $ 322,921 $ 79,272 $ 16,034
Cost of care delivery (23,927) (11,823) (289,672) (67,254) (19,810)
Other operating income (expense)     (400,754) (173,042) (156,548)
Change in fair value of warrant liabilities 5,575   27,811    
Exchange gain / (loss) (447) (573) 868 (2,836) 17,075
Gain on sale of subsidiary   3,917 3,917    
Gain on remeasurement of equity interest     10,495    
Share of loss of equity-accounted investees   (455) (2,602) (1,124)  
Segment EBITDA (75,517) (4,013) (327,016) (164,984) (143,249)
Depreciation and amortization (9,458) (5,848) (35,004) (14,487) (2,496)
Operating loss (90,103) (12,750) (402,509) (175,511) (162,820)
Operating segment, excluding materially reconciling items          
Disclosure of operating segments [line items]          
Revenue 266,517 70,920 322,873 79,194 16,043
Operating segments          
Disclosure of operating segments [line items]          
Revenue 266,453 70,924 322,870 79,060 16,073
Cost of care delivery (24,527) (14,462) (297,130) (76,186) (26,240)
Other operating income (expense)     (392,528) (158,942) (148,508)
Change in fair value of warrant liabilities 5,575   27,811    
Exchange gain / (loss) (18,382) 1,107 (265) 17,217 16,815
Gain on sale of subsidiary   3,917 2,687    
Gain on remeasurement of equity interest     10,495    
Share of loss of equity-accounted investees   (455) (2,602) (1,124)  
Segment EBITDA (93,339) (3,030) (328,662) (139,975) (141,860)
Reconciliation adjustments          
Disclosure of operating segments [line items]          
Revenue (7) 369 51 212 (39)
Cost of care delivery 600 2,639 7,458 8,932 6,430
Other operating income (expense)     (8,226) (14,100) (8,040)
Exchange gain / (loss) 17,935 (1,680) 1,133 (20,053) 260
Gain on sale of subsidiary     1,230    
Segment EBITDA 17,822 (983) 1,646 (25,009) (1,389)
Unallocated amounts          
Disclosure of operating segments [line items]          
Revenue (71) 373 48 78 (9)
Inter-segment revenue          
Disclosure of operating segments [line items]          
Revenue (64) 4 3 134 (30)
UK | Operating segment, excluding materially reconciling items          
Disclosure of operating segments [line items]          
Revenue 15,670 41,242 88,967 44,000 14,633
UK | Operating segments          
Disclosure of operating segments [line items]          
Revenue 15,670 41,242 91,172 45,194 18,714
Cost of care delivery (11,872) (9,269) (41,542) (34,600) (25,707)
Other operating income (expense)     (114,975) (127,762) (119,895)
Exchange gain / (loss) (4,078) (632) (1,844) 403 314
Segment EBITDA (31,505) 4,899 (67,189) (116,765) (126,574)
UK | Inter-segment revenue          
Disclosure of operating segments [line items]          
Revenue     2,205 1,194 4,081
US | Operating segment, excluding materially reconciling items          
Disclosure of operating segments [line items]          
Revenue 250,512 29,244 232,296 32,226  
US | Operating segments          
Disclosure of operating segments [line items]          
Revenue 250,512 29,244 228,332 29,132 (2,669)
Cost of care delivery (12,394) (4,597) (253,998) (34,381) (160)
Other operating income (expense)     (105,602) (27,190) (23,273)
Exchange gain / (loss) 2,353 (49) 189 (246) (83)
Share of loss of equity-accounted investees   (455) (2,602)    
Segment EBITDA (41,257) (11,090) (133,681) (32,685) (26,185)
US | Inter-segment revenue          
Disclosure of operating segments [line items]          
Revenue     (3,964) (3,094) (2,669)
All other segments | Operating segment, excluding materially reconciling items          
Disclosure of operating segments [line items]          
Revenue 335 434 1,610 2,968 1,410
All other segments | Operating segments          
Disclosure of operating segments [line items]          
Revenue 271 438 3,366 4,734 28
Cost of care delivery (261) (596) (1,590) (7,205) (373)
Other operating income (expense)     (171,951) (3,990) (5,340)
Change in fair value of warrant liabilities 5,575   27,811    
Exchange gain / (loss) (16,657) 1,788 1,390 17,060 16,584
Gain on sale of subsidiary   3,917 2,687    
Gain on remeasurement of equity interest     10,495    
Share of loss of equity-accounted investees       (1,124)  
Segment EBITDA (20,577) 3,161 (127,792) 9,475 10,899
All other segments | Inter-segment revenue          
Disclosure of operating segments [line items]          
Revenue $ (64) $ 4 $ 1,756 $ 1,766 $ (1,382)